Osimertinib Impurity 18 | CAS 1823445-36-8 - Request Quote
Osimertinib Impurity 18
| SZ CAT No: | SZ-O014041 |
| CAS No | 1823445-36-8 |
| Mol.F. | C9H9FN2O4 |
| Mol.Wt. | 228.2 |
| Inv. Status | Synthesis on demand |
Chemical Name :
Shipping Temperature :
HSN Code :
Country of Origin :
Smiles :
Usage Note:
Osimertinib Impurity 18 is chemically N-(4-Fluoro-2-methoxy-5-nitrophenyl)acetamide. Osimertinib Impurity 18 is supplied with detailed characterization data compliant with regulatory guideline. Osimertinib Impurity 18 can be used for the analytical method development, method validation (AMV), Quality Controlled (QC) application for Abbreviated New Drug Application (ANDA) or during commercial production of Osimertinib.
The product can be used as reference standards and further traceability against pharmacopeial standards (USP or EP) can be provided based on feasibility. SynZeal products are for analytical purpose only and not for human use.
Applications & Regulatory Use Cases
Buy 1823445-36-8
Purchase 1823445-36-8
Order 1823445-36-8
Enquire 1823445-36-8
price of 1823445-36-8
1823445-36-8 Supplier
1823445-36-8 Manufacturer
1823445-36-8 Exporter
buy high quality Osimertinib Impurity 18
Purchase Osimertinib Impurity 18
Osimertinib Impurity 18 suppliers
Osimertinib Impurity 18 manufacturers
Osimertinib Impurity 18 price
Order Osimertinib Impurity 18
Enquire Osimertinib Impurity 18
Osimertinib Impurity 18 cost
Osimertinib Impurity 18 Supplier
Osimertinib Impurity 18 Distributor
Osimertinib Impurity 18 for Method Validation
Osimertinib Reference Standard
Osimertinib Impurity 18 for ANDA Filing
Osimertinib Impurity 18 for Forced Degradation Studies
Osimertinib Impurity 18 Identification Standards
Osimertinib Impurity 18 for DMF Filing
Related Products
Disclaimer
SynZeal product information given on this website is as per the existing understanding while publishing the details on website. The customer is responsible for assessing the accuracy of the information at the time of actual purchase.
SynZeal will update these details as per new developments or findings in product specifications without further notice.


